Aprea Therapeutics Cash Flow Statement 2017-2024 | APRE

Fifteen years of historical annual cash flow statements for Aprea Therapeutics (APRE).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020201920182017
$-14.29$-112.66$-37.13$-53.48$-28.06$-15.53$-15.19
$0.01$0.19$0.27$0.23$0.17$0.01$0.01
$0.48$89.22$7.50$5.87$0.02$-0.63$-0.27
$0.49$89.41$7.77$6.10$0.19$-0.62$-0.26
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0.83$-0.86$-2.73$2.33$0.44$0.21$0.33
$0.98$2.00$-0.38$-0.68$-2.79$-0.02$0.00
$1.62$-1.76$-8.33$5.57$1.16$0.90$1.45
$-12.18$-25.01$-37.69$-41.80$-26.71$-15.25$-14.00
$-0.09$0$0$-0.03$-0.03$0.00$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-0.09$0$0$-0.03$-0.03$0.00$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$5.79$0.68$1.75$0.15$86.98$0.00$0
$5.79$0.68$1.75$0.15$92.58$56.37$23.34
$0$0$0$0$0$0$0
$-0.65$0$0$0$0$0$0
$5.14$0.68$1.75$0.15$92.58$56.37$23.34
$-7.14$-24.29$-35.94$-41.07$64.41$41.27$10.74
$0.44$16.98$7.81$4.98$1.35$0.33$0.40
$0$0$0$0$0$0$0